Study: Nalls, 2014

Population Ethnicity Diagnosis Source # Cases (% women) # Controls (% women) AAO (sd) AAO range AAE (sd) AAE range Ctrl age (sd) Ctrl age range # Polymorphisms
Iceland (CHARGE-AGES-RS) C ICD codes, medication PO 146 (55%) 5609 (59%) 75 (8) - - - 69 (9) - 8,205

Polymorphisms in this population [-]

Polymorphism Location (hg19) Gene Allele contrast Ethnicity # Studies # Samples 1000G CEU 1000G CHB+JPT Meta OR (95%CI) I2 (95%CI) Meta P-value
rs850731 chr17:42454270 ITGA2B T vs. C All: C 15 108,990 - 0.358 (C) 0.93 (0.90-0.97) 0 (0-46) 6.30e-05
rs850729 chr17:42454806 ITGA2B C vs. T All: C 14 105,041 - - 0.92 (0.89-0.95) 0 (0-41) 2.49e-06
rs17544947 chr17:42918966 HIGD1B [-4755bp] G vs. T All: C 15 108,990 0.242 (G) - 1.08 (1.04-1.11) 0 (-) 7.83e-05
rs73984100 chr17:42929985 EFTUD2 T vs. G All: C 15 108,990 0.267 (T) - 1.08 (1.04-1.12) 0 (-) 4.58e-05
rs75193889 chr17:43060768 C1QL1 [+15329bp] G vs. T All: C 15 108,990 0.033 (G) - 0.81 (0.75-0.87) 0 (0-42) 5.85e-08
rs4986167 chr17:43202492 PLCD3 G vs. A All: C 15 108,990 - - 0.99 (0.95-1.02) 27 (0-61) 0.409
rs77403959 chr17:43208068 PLCD3 T vs. C All: C 15 108,990 0.042 (T) - 0.82 (0.75-0.89) 0 (0-43) 2.92e-06
rs1053578 chr17:43221285 ACBD4 C vs. T All: C 15 108,990 0.042 (C) - 0.81 (0.75-0.89) 0 (0-47) 1.90e-06
rs11079501 chr17:43349882 SPATA32 [+10403bp] T vs. C All: C 12 96,250 - 0.125 (C) 0.82 (0.69-0.96) 0 (-) 0.017
rs2074289 chr17:43364914 SPATA32 [+25435bp] A vs. G All: C 13 100,199 - 0.125 (G) 0.83 (0.74-0.94) 0 (-) 0.003
rs7222094 chr17:43367653 SPATA32 [+28174bp] C vs. T All: C 15 108,990 0.408 (C) 0.117 (T) 0.94 (0.91-0.97) 0 (0-46) 4.90e-05
rs721579 chr17:43370481 SPATA32 [+31002bp] T vs. C All: C 15 108,990 0.225 (T) 0.392 (C) 0.90 (0.86-0.93) 0 (0-41) 3.11e-09
rs2867316 chr17:43376447 RNA5SP443 [-28285bp] T vs. C All: C 15 108,990 0.275 (T) 0.317 (C) 0.90 (0.87-0.93) 0 (0-41) 8.29e-10
rs7221403 chr17:43380666 RNA5SP443 [-24066bp] C vs. A All: C 15 108,990 0.417 (C) - 0.93 (0.90-0.96) 0 (0-31) 4.45e-06
rs9908330 chr17:43383100 RNA5SP443 [-21632bp] G vs. A All: C 15 108,990 0.417 (G) 0.233 (A) 0.92 (0.90-0.95) 0 (0-33) 9.64e-07
rs4792847 chr17:43383484 RNA5SP443 [-21248bp] A vs. G All: C 15 108,990 0.417 (A) 0.125 (G) 0.93 (0.90-0.96) 0 (0-38) 7.71e-06
rs1476532 chr17:43383596 RNA5SP443 [-21136bp] G vs. A All: C 15 108,990 0.417 (G) 0.233 (A) 0.91 (0.88-0.94) 0 (0-40) 8.19e-08
rs7214514 chr17:43387104 RNA5SP443 [-17628bp] T vs. G All: C 15 108,990 0.275 (T) 0.317 (G) 0.90 (0.87-0.93) 0 (0-38) 1.12e-09
rs80000929 chr17:43390121 RNA5SP443 [-14611bp] G vs. A All: C 12 96,250 - 0.1 (A) 0.81 (0.69-0.95) 0 (-) 0.010
rs74996617 chr17:43390343 RNA5SP443 [-14389bp] G vs. A All: C 12 96,250 - 0.117 (A) 0.81 (0.69-0.95) 0 (-) 0.009
rs79760062 chr17:43390763 RNA5SP443 [-13969bp] A vs. G All: C 12 96,250 - 0.108 (G) 0.81 (0.69-0.95) 0 (-) 0.009
rs4792849 chr17:43395178 RNA5SP443 [-9554bp] A vs. G All: C 15 108,990 0.225 (A) 0.383 (G) 0.90 (0.86-0.93) 0 (0-32) 2.02e-09
rs117642368 chr17:43399058 RNA5SP443 [-5674bp] C vs. G All: C 15 108,990 0.067 (C) - 0.77 (0.73-0.82) 0 (0-47) 3.08e-16
rs4328483 chr17:43401540 RNA5SP443 [-3192bp] T vs. G All: C 15 108,990 0.367 (T) 0.342 (G) 0.92 (0.89-0.95) 0 (0-25) 3.14e-07
rs4792814 chr17:43403005 RNA5SP443 [-1727bp] T vs. C All: C 15 108,990 0.358 (T) 0.342 (C) 0.92 (0.89-0.95) 0 (0-22) 5.90e-07
rs4792850 chr17:43403777 RNA5SP443 [-955bp] A vs. C All: C 15 108,990 0.358 (A) 0.35 (C) 0.92 (0.89-0.95) 0 (0-22) 6.03e-07
rs2552462 (chr17:44708736) chr17:44491152 intergenic A vs. T All: C 10 31,764 - - 1.55 (1.39-1.73) 35 (0-69) 2.78e-15
rs199460 chr17:44764775 NSF A vs. C All: C 15 108,990 - - 1.34 (1.26-1.43) 35 (0-65) 7.10e-21
rs62074079 (chr17:44764981) chr17:44547284 LRRC37A2 [-41593bp] C vs. G All: C 15 108,990 - - 1.46 (1.37-1.56) 11 (0-48) 1.61e-33
rs143572569 chr17:44776843 NSF T vs. C All: C 13 42,826 - - 1.62 (1.47-1.78) 10 (0-49) 7.38e-23
rs200403 chr17:44781143 NSF A vs. C All: C 15 108,990 - - 1.27 (1.21-1.32) 26 (0-60) 2.49e-27
rs116988420 chr17:44782279 NSF C vs. G All: C 15 108,990 - - 1.46 (1.37-1.55) 6 (0-57) 1.40e-34
rs17692129 chr17:44793283 NSF T vs. C All: C 11 94,570 0.317 (T) 0.208 (T) 1.07 (1.03-1.11) 24 (0-62) 1.83e-04
rs199451 chr17:44801784 NSF A vs. G All: C 15 108,990 0.208 (A) - 0.78 (0.75-0.81) 10 (0-48) 5.80e-34
rs35937770 chr17:44808360 NSF A vs. G All: C 11 94,570 0.308 (A) 0.217 (A) 1.08 (1.04-1.12) 24 (0-62) 8.26e-05
rs199447 chr17:44812188 NSF T vs. C All: C 15 108,990 0.208 (T) - 0.78 (0.75-0.81) 12 (0-50) 5.75e-34
rs9912530 chr17:44836302 NSF [+1472bp] T vs. C All: C 15 108,990 0.275 (T) 0.275 (C) 0.81 (0.78-0.84) 23 (0-58) 1.42e-26
rs199530 chr17:44836653 NSF [+1823bp] G vs. A All: C 15 108,990 0.242 (G) 0.275 (A) 0.80 (0.77-0.83) 26 (0-60) 3.86e-29
rs199528 chr17:44843136 WNT3 T vs. C All: C 15 108,990 0.192 (T) - 0.77 (0.74-0.81) 19 (0-56) 2.37e-34
rs199526 chr17:44847707 WNT3 C vs. G All: C 15 108,990 0.192 (C) 0.292 (G) 0.78 (0.75-0.82) 20 (0-56) 9.25e-32
rs199525 chr17:44847834 WNT3 G vs. T All: C 15 108,990 0.2 (G) - 0.77 (0.74-0.81) 19 (0-56) 2.78e-34
rs3809857 chr17:44848314 WNT3 T vs. G All: C 11 94,570 0.3 (T) 0.217 (T) 1.10 (1.06-1.15) 34 (0-68) 9.26e-06
rs62074125 chr17:44852612 WNT3 C vs. A All: C 11 94,570 0.25 (C) - 1.16 (1.10-1.22) 28 (0-64) 3.06e-08
rs199518 chr17:44854580 WNT3 A vs. C All: C 15 108,990 0.217 (A) 0.325 (C) 0.79 (0.76-0.82) 24 (0-59) 1.74e-28
rs199517 chr17:44854587 WNT3 A vs. G All: C 15 108,990 0.233 (A) 0.283 (G) 0.79 (0.76-0.82) 23 (0-59) 1.42e-28
rs199510 chr17:44857929 WNT3 C vs. A All: C 15 108,990 - - 1.30 (1.24-1.35) 24 (0-59) 1.69e-32
rs199508 chr17:44858838 WNT3 C vs. G All: C 15 108,990 0.225 (C) 0.425 (G) 0.79 (0.76-0.83) 27 (0-61) 1.31e-29
rs199498 chr17:44865603 WNT3 C vs. T All: C 15 108,990 0.192 (C) 0.442 (T) 0.77 (0.74-0.81) 6 (0-56) 3.49e-29
rs3851781 chr17:44891301 WNT3 T vs. C All: C 15 108,990 0.492 (T) 0.267 (C) 1.09 (1.05-1.12) 0 (0-45) 5.07e-07
rs72836354 chr17:44899464 WNT3 A vs. G All: C 15 108,990 0.475 (A) 0.233 (G) 1.09 (1.05-1.12) 0 (0-22) 3.00e-07